Detalhe da pesquisa
1.
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review.
Am J Respir Crit Care Med;
203(6): 689-698, 2021 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32966751
2.
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis.
Respir Res;
21(1): 5, 2020 Jan 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31907054
3.
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
Am J Respir Crit Care Med;
198(1): 51-57, 2018 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29442524
4.
Missing data sensitivity analysis for recurrent event data using controlled imputation.
Pharm Stat;
13(4): 258-64, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24931317
5.
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.
Lancet Respir Med;
2(1): 63-72, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24461903
6.
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
Ann Am Thorac Soc;
11(4): 531-6, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24606022